| Long name: |
OPRD1 Primary Polyclonal Antibody |
| Also known as: |
OPRD1 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
Delta-type opioid receptor |
| Specificity: |
This antibody may also have a weak secondary cross-reaction with Mu-type opioid receptor, This is predicted based upon a 79% non-contiguous sequence similarity, which is primarily expressed in the adrenal gland and testis, This is a highly specific antibody against Delta-type opioid receptor |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
109-122/372 |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human OPRD1 |
| Gene ID number: |
4985 |
| Swiss Prot: |
P41143 |
| Tested Applications: |
WB |
| Recommended dilutions: |
WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance, Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, Plays a role in developing analgesic tolerance to morphine, Plays a role in the perception of pain and in opiate-mediated analgesia, Signaling leads to the inhibition of adenylate cyclase activity, such as adenylate cyclase, G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
D-OR-1, DOR-1, Delta-type opioid receptor, OPRD1, OPRD |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
OPRD1 |
| Short name: |
OPRD1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
OPRD1 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
8153 |
| Gene: |
OPRD1 |
More about : OPRD1 |
| Long gene name: |
opioid receptor delta 1 |
| Synonyms gene name: |
delta 1 , opioid receptor |
| Locus: |
1p35, 3 |
| Discovery year: |
1993-03-11 |
| GenBank acession: |
U10504 |
| Entrez gene record: |
4985 |
| Pubmed identfication: |
8415697 |
| RefSeq identity: |
NM_000911 |
| Classification: |
Opioid receptors |
| Havana BLAST/BLAT: |
OTTHUMG00000003646 |